Hyperfine (HYPR) Free Cash Flow (2021 - 2026)
Hyperfine (HYPR) reported Free Cash Flow of -$9.0 million for Q1 2026, up 7.4% on a YoY basis from -$8.4 million in Q1 2025, and down 72.67% quarter-over-quarter from -$5.2 million in Q4 2025.
Hyperfine (HYPR) Free Cash Flow (2021 - 2026) Analysis & Trends
Hyperfine has reported Free Cash Flow for 6 years, with the latest figure at -$9.0 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 7.4% year-over-year to -$9.0 million; the trailing twelve-month figure through Mar 2026 stood at -$27.3 million (up 22.73% YoY), and the FY2025 full-year result was -$28.0 million, up 27.83% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$9.0 million, down from -$5.2 million in the prior quarter.
- The five-year high for Free Cash Flow was -$5.2 million in Q4 2025, with the low at -$27.6 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$11.3 million across 5 years, with a median of -$9.7 million in 2023.
- Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 260.46% — and 2023, when it surged 50.98%.
- Hyperfine's Free Cash Flow stood at -$15.5 million in 2022, then soared by 34.23% to -$10.2 million in 2023, then rose by 21.71% to -$8.0 million in 2024, then jumped by 34.44% to -$5.2 million in 2025, then slumped by 72.67% to -$9.0 million in 2026.
- The last three Free Cash Flow figures came in at -$9.0 million (Q1 2026), -$5.2 million (Q4 2025), and -$5.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn | -9.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.04 Mn |
| Mar 31, 2026 | -9.04 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Dec 31, 2025 | -5.23 Mn |
| Sep 30, 2025 | -5.50 Mn |
| Sep 30, 2025 | -5.50 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Jun 30, 2025 | -7.49 Mn |
| Mar 31, 2025 | -9.76 Mn |
| Mar 31, 2025 | -9.76 Mn |
| Dec 31, 2024 | -7.98 Mn |
| Dec 31, 2024 | -7.98 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -8.86 Mn |
| Jun 30, 2024 | -8.86 Mn |
| Mar 31, 2024 | -13.25 Mn |
| Mar 31, 2024 | -13.25 Mn |
| Dec 31, 2023 | -10.20 Mn |
| Dec 31, 2023 | -10.20 Mn |